Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement

NCT06066840 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
45
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators